As vaccine research continues to evolve, scientists are placing greater emphasis not only on antigen design but also on selecting adjuvants that can deliver stronger, more consistent immune respo...
Influenza vaccines represent one of the largest segments of the global vaccine market (with the global market size exceeding $8 billion by 2025). However, the protective efficacy of traditional s...
In vaccine development and immunotherapy, one of the most critical challenges is not only delivering an antigen, but ensuring the immune system responds to it in a strong, controlled, and durable...
